TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019

Intro: In 2010, PCV10 was introduced in the Colombian National Immunization Program (NIP) for children, with good vaccination coverage >82% since 2012. However, the NIP does not include routine pneumococcal vaccination for older adults. We assessed trends in mortality rate (MR) due to potential p...

Full description

Bibliographic Details
Main Authors: C. Parellada, L.F. Reyes, C. Beltran, M. Rojas, C. Zampirolli, A. Abreu, P. Pungartnik, J.C. Orengo, F. De La Hoz
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223005957
_version_ 1797745240536252416
author C. Parellada
L.F. Reyes
C. Beltran
M. Rojas
C. Zampirolli
A. Abreu
P. Pungartnik
J.C. Orengo
F. De La Hoz
author_facet C. Parellada
L.F. Reyes
C. Beltran
M. Rojas
C. Zampirolli
A. Abreu
P. Pungartnik
J.C. Orengo
F. De La Hoz
author_sort C. Parellada
collection DOAJ
description Intro: In 2010, PCV10 was introduced in the Colombian National Immunization Program (NIP) for children, with good vaccination coverage >82% since 2012. However, the NIP does not include routine pneumococcal vaccination for older adults. We assessed trends in mortality rate (MR) due to potential pneumococcal pneumonia (PPP) from 2006-2019. Methods: This ecological time-series study used Colombian nationwide administrative databases. We analyzed the pre-PCV10 (2006-2009) and post-PCV10 (2012-2019) periods, excluding the years 2010 and 2011 (transition period). ICD-10 codes included J13-J18. MRs were calculated per 100,000 people and stratified by age groups (<1, 1-4, 5-17, 18-49, 50-59, 60-64 and ≥65 years). The percent of change was calculated by the difference between the average rate in the pre-PCV and post-PCV periods for each age group. Joinpoint regression analysis was performed to assess changes in MRs. Annual percent changes (APCs) for each line segment and average APC (AAPC) over 2006-2019 were estimated. Findings: During 2006-2019, there were 102,082 deaths due to PPP. The highest MRs were seen for the age groups <1 and ≥65 years. Mean MRs decreased in age groups <18 years in the post-PCV10 period. A decreasing trend was seen primarily in those <1 year (AAPC -6.8; 95%CI: -8.6;-5.1) and 1-4 years (AAPC -5.0; 95%CI: -7.2;-2.8%) from 2006-2019. In contrast, for the age groups 50-59 years and 60-64 years, there was a significant increasing trend (AAPC 1.6%;95%CI 1.7%-5.1% and AAPC 3.4; 95%CI: 1.7;5.1, respectively) from 2006-2019. In ≥65 years, there was a significant increasing trend from 2011-2016 (APC 6.6; 95% CI: 0.5;13.1), followed by a non-significative decrease trend from 2016-2019 (APC -2.8; 95%CI-10.4;5.5). Conclusion: This study provided additional evidence for the benefits of childhood PCV programs. For older adults, MR has been consistently higher in post-vaccination period compared to pre-vaccination. These findings can inform decision-makers about the needs for pneumococcal vaccination among older adults in Colombia.
first_indexed 2024-03-12T15:21:30Z
format Article
id doaj.art-21e209c1d2b54e6387bb6531627fd926
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-03-12T15:21:30Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-21e209c1d2b54e6387bb6531627fd9262023-08-11T05:32:16ZengElsevierInternational Journal of Infectious Diseases1201-97122023-08-01134S10TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019C. Parellada0L.F. Reyes1C. Beltran2M. Rojas3C. Zampirolli4A. Abreu5P. Pungartnik6J.C. Orengo7F. De La Hoz8MSD Brazil, Outcomes Research, São Paulo, BrazilUniversidad de la Sabana, Clínica Universidad de La Sabana, Chía, ColombiaMSD Colombia, Scientific and Medical Affairs, Bogota, ColombiaMSD Colombia, Scientific and Medical Affairs, Bogota, ColombiaIQVIA, Real-World Insights, São Paulo, BrazilIQVIA, Real-World Insights, São Paulo, BrazilIQVIA, Real-World Insights, São Paulo, BrazilMSD (IA) LLC, Outcomes Research, Guaynabo, Puerto RicoUniversidad Nacional de Colombia, Public Health, Bogota, ColombiaIntro: In 2010, PCV10 was introduced in the Colombian National Immunization Program (NIP) for children, with good vaccination coverage >82% since 2012. However, the NIP does not include routine pneumococcal vaccination for older adults. We assessed trends in mortality rate (MR) due to potential pneumococcal pneumonia (PPP) from 2006-2019. Methods: This ecological time-series study used Colombian nationwide administrative databases. We analyzed the pre-PCV10 (2006-2009) and post-PCV10 (2012-2019) periods, excluding the years 2010 and 2011 (transition period). ICD-10 codes included J13-J18. MRs were calculated per 100,000 people and stratified by age groups (<1, 1-4, 5-17, 18-49, 50-59, 60-64 and ≥65 years). The percent of change was calculated by the difference between the average rate in the pre-PCV and post-PCV periods for each age group. Joinpoint regression analysis was performed to assess changes in MRs. Annual percent changes (APCs) for each line segment and average APC (AAPC) over 2006-2019 were estimated. Findings: During 2006-2019, there were 102,082 deaths due to PPP. The highest MRs were seen for the age groups <1 and ≥65 years. Mean MRs decreased in age groups <18 years in the post-PCV10 period. A decreasing trend was seen primarily in those <1 year (AAPC -6.8; 95%CI: -8.6;-5.1) and 1-4 years (AAPC -5.0; 95%CI: -7.2;-2.8%) from 2006-2019. In contrast, for the age groups 50-59 years and 60-64 years, there was a significant increasing trend (AAPC 1.6%;95%CI 1.7%-5.1% and AAPC 3.4; 95%CI: 1.7;5.1, respectively) from 2006-2019. In ≥65 years, there was a significant increasing trend from 2011-2016 (APC 6.6; 95% CI: 0.5;13.1), followed by a non-significative decrease trend from 2016-2019 (APC -2.8; 95%CI-10.4;5.5). Conclusion: This study provided additional evidence for the benefits of childhood PCV programs. For older adults, MR has been consistently higher in post-vaccination period compared to pre-vaccination. These findings can inform decision-makers about the needs for pneumococcal vaccination among older adults in Colombia.http://www.sciencedirect.com/science/article/pii/S1201971223005957
spellingShingle C. Parellada
L.F. Reyes
C. Beltran
M. Rojas
C. Zampirolli
A. Abreu
P. Pungartnik
J.C. Orengo
F. De La Hoz
TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
International Journal of Infectious Diseases
title TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
title_full TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
title_fullStr TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
title_full_unstemmed TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
title_short TRENDS IN MORTALITY OF POTENTIAL PNEUMOCOCCAL PNEUMONIA IN COLOMBIA, 2006-2019
title_sort trends in mortality of potential pneumococcal pneumonia in colombia 2006 2019
url http://www.sciencedirect.com/science/article/pii/S1201971223005957
work_keys_str_mv AT cparellada trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT lfreyes trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT cbeltran trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT mrojas trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT czampirolli trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT aabreu trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT ppungartnik trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT jcorengo trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019
AT fdelahoz trendsinmortalityofpotentialpneumococcalpneumoniaincolombia20062019